ArticleJournal for immunotherapy of cancer2020

Correction: Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma.

No numbers read from the abstract.

Not cited yet